Skip to content
2000
Volume 24, Issue 2
  • ISSN: 1389-2010
  • E-ISSN: 1873-4316

Abstract

The vascular endothelial growth factor (VEGF) family plays a major role in tumors and ophthalmic diseases. However, increasingly more data reported its potential in regulating lipids. With its biological functions mainly expressed in lymphatic vessels, some factors in the families, like VEGF-A and VEGF-C, have been proved to regulate intestinal absorption of lipids by affecting chylous ducts. Other effects, including regulating lipoprotein lipase (LPL), endothelial lipase (EL), and recombinant syndecan 1 (SDC1), have also been confirmed. However, given the scant-related studies, further research should be conducted to examine the concrete mechanisms and provide pragmatic ways to apply them in the clinic. The VEGF family may treat dyslipidemia in specific ways that are different from common methods and concurrently contribute to the treatment of other metabolic diseases, like diabetes and obesity.

Loading

Article metrics loading...

/content/journals/cpb/10.2174/1389201023666220506105026
2023-02-01
2025-04-02
Loading full text...

Full text loading...

/content/journals/cpb/10.2174/1389201023666220506105026
Loading

  • Article Type:
    Review Article
Keyword(s): adipose tissue; atherosclerosis; intestine; lipid metabolism; lipoprotein lipase; VEGF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test